Net sales fell to $326.0 million from $359.7 million in the prior-year period. The company reported a net loss of $159.7 million, or $1.73 per diluted share, compared with net income of $36.7 million, or $0.36 per diluted share, last year.

BlackBerry reported fiscal Q1 2027 revenue of approximately $153 million, up 26% year-over-year. Adjusted EBITDA grew 144% year-over-year, reflecting improved operational efficiency.

Reported adjusted EPS of $1.73, beating consensus estimates of approximately $1.70–$1.71. Net sales rose 22.9% year-over-year to $2.48 billion, driven by strong demand and acquisitions.

Net sales reached $1.198 billion for the quarter ended May 31, 2026, marking a 1.6% increase year over year. Adjusted diluted earnings per share came in at $5.31, exceeding analyst estimates of approximately $5.12.

Net sales rose 16.7% year-over-year to reflect strong contribution from the McCormick de Mexico acquisition, with organic sales growth of 1.7%. Adjusted earnings per share reached $0.80, beating consensus estimates and rising 15.9% from $0.69 in the prior-year quarter.

Darden reported fiscal 2026 fourth-quarter total sales of $3.72 billion, up 13.7% year-over-year, including a 53rd week. Adjusted diluted earnings per share from continuing operations reached $3.66, exceeding analyst expectations.

ALOY fell -17.28% during regular trading on June 25, dropping to $13.79 from the prior session's close of $16.67. The selloff was triggered by an after-hours announcement on June 24 of a $100 million private placement of common stock to institutional investors.

MAAS dropped -13.46% during regular market hours on June 24, falling to $18.38 from a previous close of $21.24, as the stock reversed sharply from its parabolic rally. The primary catalyst was a severe post-earnings reality check: the company's June 23 interim financial filing revealed a staggering -$64.61 EPS on just $0.22 million in revenue, exposing a deep disconnect between the stock's valuation and its fundamentals.

ENHA shares fell -14.10% during regular trading on June 25, dropping to $3.015 from a previous close of $3.51, extending a multi-day selloff. The decline follows the June 18 closing of the initial tranche of a $50 million PIPE financing priced at $3.89 per share, with the stock now trading significantly below that level.

AQST closed the June 25 regular session sharply lower and continued sliding in after-hours to $4.21, marking a -15.63% decline from the prior session's close of $4.99. The sell-off occurred primarily during regular market hours, with after-hours trading confirming the downside pressure and no meaningful bounce.

HTT shares surged approximately 38.8% over the past 30 days, driven primarily by a modified Dutch auction tender offer to repurchase up to 39 million ADSs. The stock jumped 23.4% on May 26 alone following the tender offer announcement, which set a price range of $2.80 to $3.20 per ADS.

AMAT shares surged approximately +6.97% in premarket trading on June 25, 2026, rising from a prior close of $588.97 to roughly $630.00. The primary catalyst was Micron Technology's (MU) historic fiscal Q3 2026 earnings beat — revenue of $41.46 billion and adjusted EPS of $25.11, both far above estimates — which directly validates accelerating AI-driven capital expenditure that flows through to Applied Materials' equipment order book.

SNDK shares surged approximately +15.33% in premarket trading on June 25, 2026, rising from a prior close of $1,914.46 to roughly $2,208.00. The primary catalyst was sector sympathy momentum ignited by Micron Technology's (MU) historic fiscal Q3 2026 earnings report, which reported revenue of $41.46 billion — more than four times year-ago levels — and issued Q4 guidance of ~$50 billion, far exceeding all analyst estimates.

MU shares surged approximately +16.48% in premarket trading on June 25, 2026, rising from a prior close of $1,048.51 to roughly $1,221.28. The primary catalyst was a historic fiscal Q3 2026 earnings report in which revenue quadrupled year-over-year to $41.46 billion — more than $5 billion above analyst consensus — marking the fifth consecutive quarterly revenue record.

INVE shares plunged approximately 21% in premarket trading on June 25, 2026, falling from the prior regular-session close of $3.69 to roughly $2.92. The primary catalyst was a Q2 2026 earnings miss combined with guidance that fell short of analyst consensus, reigniting concerns about Identiv's commercial ramp and path to profitability.

SPRY shares plunged approximately 26% in premarket trading on June 25, 2026, falling from the prior session's close of $10.54 to roughly $7.80. The primary catalyst was a late Wednesday commercial update confirming no new commercial formulary additions for neffy (epinephrine nasal spray) in the July 1, 2026 payer coverage cycle — a significant miss against market expectations.

FUL shares declined approximately 6.38% in premarket trading on June 25, 2026, falling to around $60.45 from the prior session's close of $62.75. The primary catalyst was H.B. Fuller's formal confirmation of a £715 million (~$942M) all-cash acquisition of Advanced Medical Solutions Group (AMS), a UK-based medical wound-care company.

Daktronics reported record full-year net sales of $838.7 million, up 10.9% from fiscal 2025. Fourth-quarter net sales reached $208.6 million, a 20.9% increase year-over-year.

Net revenue reached $950 million, up 5.8% year-over-year with organic revenue rising 2.6%. Reported diluted EPS of $1.23 and adjusted diluted EPS of $1.41, a 19% increase from the prior year.

Net revenues reached $2.21 billion, up 35% year-over-year. Diluted earnings per share totaled $1.02, exceeding consensus estimates.